abrdn plc Acquires 506,011 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

abrdn plc increased its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 108.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 974,350 shares of the real estate investment trust’s stock after acquiring an additional 506,011 shares during the period. abrdn plc owned about 0.42% of Sabra Health Care REIT worth $13,904,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. CWM LLC grew its holdings in Sabra Health Care REIT by 363.5% during the third quarter. CWM LLC now owns 1,780 shares of the real estate investment trust’s stock valued at $25,000 after purchasing an additional 1,396 shares during the period. SG Americas Securities LLC grew its holdings in Sabra Health Care REIT by 30.3% during the third quarter. SG Americas Securities LLC now owns 30,920 shares of the real estate investment trust’s stock valued at $431,000 after purchasing an additional 7,184 shares during the period. HGK Asset Management Inc. bought a new position in Sabra Health Care REIT during the third quarter valued at $299,000. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Sabra Health Care REIT by 7.6% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 85,427 shares of the real estate investment trust’s stock valued at $1,191,000 after purchasing an additional 6,032 shares during the period. Finally, Caerus Investment Advisors LLC bought a new position in Sabra Health Care REIT during the third quarter valued at $214,000. 99.40% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Mizuho increased their price objective on Sabra Health Care REIT from $15.00 to $17.00 and gave the company a “buy” rating in a report on Wednesday, January 3rd. Deutsche Bank Aktiengesellschaft started coverage on Sabra Health Care REIT in a research report on Tuesday, January 30th. They set a “buy” rating and a $21.00 target price on the stock. Finally, Wedbush restated an “outperform” rating and set a $17.00 target price on shares of Sabra Health Care REIT in a research report on Thursday, February 29th. Five research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $15.77.

Sabra Health Care REIT Trading Down 0.4 %

Shares of SBRA stock opened at $13.65 on Friday. The company has a debt-to-equity ratio of 0.86, a quick ratio of 3.41 and a current ratio of 3.41. Sabra Health Care REIT, Inc. has a 52-week low of $10.30 and a 52-week high of $14.91. The company has a market capitalization of $3.16 billion, a PE ratio of 273.00, a price-to-earnings-growth ratio of 4.92 and a beta of 1.16. The business’s fifty day moving average is $14.06 and its 200 day moving average is $14.04.

Sabra Health Care REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, February 29th. Stockholders of record on Tuesday, February 13th were paid a dividend of $0.30 per share. The ex-dividend date was Monday, February 12th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 8.79%. Sabra Health Care REIT’s dividend payout ratio (DPR) is currently 2,400.00%.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.